CRISPR-targeting produced a point mutation that resulted in the amino acid substitution of arginine with histidine at position 79 (R97H), which is equivalent to R89H in human patients with midline brain defects. (J:296537)
查看原文 参与反馈
CRISPR-targeting produced a point mutation that resulted in the amino acid substitution of arginine with histidine at position 79 (R97H), which is equivalent to R89H in human patients with midline brain defects. (J:296537)